Αρχική World News FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung... World News FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung Cancer Από Ogkologos - 22 Ιανουαρίου, 2026 546 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the DeLLphi-304 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Mutational Patterns Drive Metastatic Aggressiveness of Appendiceal Adenocarcinomas 21 Δεκεμβρίου, 2022 EMA Recommends Extension of Indications for Alectinib to Adjuvant Treatment of... 23 Μαΐου, 2024 Discover and translate – a mantra to work by 17 Οκτωβρίου, 2022 Improved Survival Benefit with Encorafenib plus Cetuximab plus mFOLFOX6 in First-Line... 25 Ιουνίου, 2025 Φόρτωση περισσοτέρων HOT NEWS Making Transformative Advances against Childhood Cancer: A Conversation with Dr. Doug... Ending smoking could free up 75,000 GP appointments each month Olivia Newton-John Puts On Iconic ‘Grease’ Costume And Talks About Cancer... Tennis Legend Chris Evert Says She’s Been Diagnosed with Ovarian Cancer